References
- Carlton J, Kaltenthaler E. Amblyopia and quality of life: a systematic review. Eye. 2011;25(4):403–413. doi:10.1038/eye.2011.4.
- Carlton J. Clinicians’ perspectives of health-related quality of life (HRQoL) implications of amblyopia: a qualitative study. Br Ir Orthopt J. 2011;8:18–23.
- Carlton J. Identifying potential themes for the Child Amblyopia Treatment Questionnaire. Optom Vis Sci. 2013;90:867–873. doi:10.1097/OPX.0b013e318290cd7b.
- Carlton J. Developing the draft descriptive system for the Child Amblyopia Treatment Questionnaire (CAT-QoL): a mixed methods study. Health Qual Life Outcomes. 2013;11:174. doi:10.1186/1477-7525-11-83.
- Carlton J. Refinement of the Child Amblyopia Treatment Questionnaire (CAT-QoL) using Rasch analysis. Strabismus. 2019. doi:10.1080/09273972.2019.1601743.
- Bowling A. The philosophy, theory and practice of research. In: Research Methods in Health: Investigating Health and Health Services. 3rd ed. Maidenhead: Open University Press; 2009:125–182.
- Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the Pediatric Quality of Life Inventory. Med Care. 1999;37:126–139.
- Varni JW, Seid M, Kurtin PS. Reliability and validity of the Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales in health and patient populations. Med Care. 2001;39:800–812.
- Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability and validity. Ambul Pediatr. 2003;3:329–341.
- Hilari K, Lamping DL, Smith SC, Northcott S, Lamb A, Marshall J. Psychometric properties of the Stroke and Aphasia Quality of Life Scale (SAQOL-39) in a generic stroke population. Clin Rehabil. 2009;23(6):544–557. doi:10.1177/0269215508101729.
- Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.jclinepi.2006.03.012.
- Lamping DL, Schroter S, Marquis P, Marrel A, Duprant-Lomon I, Sagnier PP. The Community-Acquired Pneumonia symptom quesitionnaire. Chest. 2002;122:920–929.
- Streiner DL, Norman GR. Health Measurement Scales. A Practical Guide to Their Development and Use. New York: Oxford University Press; 2003.
- Smith SC, Lamping DL, Banerjee S, et al. Development of a new measure of health-related quality of life for people with dementia: DEMQOL. Psychol Med. 2007;37(5):737–746. doi:10.1017/S0033291706009469.
- Tabachnick BG, Fidell LS. Using Multivariate Statistics. 4th. Boston: Allyn and Bacon; 2001.
- Cohen K. A power primer. Psychol Bull. 1992;112:155–159.
- Pediatric Eye Disease Investigator Group. The clinical profile of moderate amblyopia in children younger than 7 years. Arch Ophthalmol. 2002;120(3): 281–287.
- Repka MX, Beck RW, Holmes JM, et al. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003;121(5):603–611. doi:10.1001/archopht.121.5.603.
- Pediatric Eye Disease Investigator Writing Committee, Rutstein RP, Quinn GE, Lazar EL, et al. A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children. Ophthalmol. 2010;117(5):998–1004. doi:10.1016/j.ophtha.2009.10.014.
- Tadic V, Hogan A, Sobti N, Knowles RL, Rahi JS. Patient-reported outcome measures (PROMs) in paediatric ophthalmology: a systematic review. Br J Ophthalmol. 2013;97(11):1369–1381. doi:10.1136/bjophthalmol-2013-303350.
- US Department of Health and Human Services Food and Drug Administration (FDA). Guidance for industry: patient-reported outcome measures: use in medicinal product development to support labeling claims. 2009. https://www.fda.gov/media/77832/download
- Buck D, Clarke MP, Powell C, Tiffin P, Drewett RF. Use of the PedsQL in childhood intermittent exotropia: estimates of feasibility, internal consistency, reliability and parent-child agreement. Qual Life Res. 2012;21(4):727–736. doi:10.1007/s11136-011-9975-7.
- Harper R, Brazier JE, Waterhouse JC, Walters SK, Jones NMB, Howard P. A comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax. 1997;52(10):879–887. doi:10.1136/thx.52.10.879.
- Kobelt G, Kirchperger I, Malone-Lee J. Quality of life aspects of the over active bladder and the effect of treatment with tolterodine. BJU Int. 1999;83:583–590.
- Espallargues M, Czoski-Murray C, Bansback N, et al. The impact of age-related macular degeneration on health state utility values. Invest Ophthalmol Vis Sci. 2005;46(11):4016–4023. doi:10.1167/iovs.05-0072.